Consequently, antibody-mediated inhibition of GAL-9 on ACM-exposed B-ALL cells induces inappropriate cell cycle progression and extensive DNA damage. This evidence concerns the gene LGALS9 and precursor B-cell acute lymphoblastic leukemia.